Composing Pieces of Audio and/or Video Information

    公开(公告)号:US20190037279A1

    公开(公告)日:2019-01-31

    申请号:US16050369

    申请日:2018-07-31

    摘要: In a method, one or more parameter values are determined for a set of pieces of audio and/or video information. The one or more parameter values are determined based at least partially on pre-defined or determined according to pre-defined rules profile information. The set of pieces of audio and/or video information represent a seamless sequence comprising combinable pieces of audio and/or video information. Further, in the method, the parameter values are used to select one or more pieces of audio and/or video information. Playback parameter values are determined for the set of pieces of audio and/or video information based at least partially on the determined one or more parameter values. The playback parameter values are provided for performing playback of the set of pieces of audio and/or video information. In order to perform the method, an apparatus, computer program and system are also disclosed.

    Benzo[b]chromeno-naphthyridin-7-one and pyrano[2′,3′:7,8]quino[2,3-b]quinoxalin-7-one compounds
    8.
    发明授权
    Benzo[b]chromeno-naphthyridin-7-one and pyrano[2′,3′:7,8]quino[2,3-b]quinoxalin-7-one compounds 失效
    苯并[b]色烯 - 萘啶-7-酮和吡喃并[2',3':7,8]喹啉并[2,3-b]喹喔啉-7-酮化合物

    公开(公告)号:US07741325B2

    公开(公告)日:2010-06-22

    申请号:US11047259

    申请日:2005-01-31

    CPC分类号: C07D491/14

    摘要: A compound selected from those of formula (I): wherein: B1, B2 represent carbon or nitrogen, X, Y, X1 and Y1 represent a group selected from hydrogen, halogen, hydroxy, alkoxy, nitro, cyano, trihaloalkyl and NRaRb wherein Ra and Rb are as defined in the description, R1 represents hydrogen or alkyl, R2 represents a group selected from hydrogen, alkyl, —OR″a, —NR′aR′b, —O-Ta-OR″a, —NR″a-Ta-NR′aR′b, NR″a—C(O)-TaH, —O—C(O)-TaH, —O-Ta-NRa′Rb′, —NR″a-Ta-OR″a, —NR″a-Ta-CO2R″a and —NR″a—C(O)-Ta-NR′aR′b wherein R′a, R′b, R″a and Ta are as defined in the description, R3, R4 represent hydrogen or alkyl, A represents a group of formula —CH(R5)—CH(R6)—, —CH═C(R7)—, —C(R7)═CH—, —C(O)—CH(R8)— or —CH(R8)—C(O)— wherein R5, R6, R7 and R8 are as defined in the description, its isomers, N-oxides, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful in the treatment of cancer.

    摘要翻译: 选自式(I)的化合物:其中:B1,B2表示碳或氮,X,Y,X1和Y1表示选自氢,卤素,羟基,烷氧基,硝基,氰基,三卤代烷基和NRaRb的基团,其中Ra 和R b如说明书中所定义,R 1表示氢或烷基,R 2表示选自氢,烷基,-OR“a,-NR'aR'b,-O-Ta-OR”a,-NR“a -Ta-NR'aR'b,NR“a-C(O)-TaH,-O-C(O)-TaH,-O-Ta-NRa'Rb',-NR”a-Ta-OR“a ,-NR“a-Ta-CO 2 R”a和-NR“a-C(O)-Ta-NR'aR'b其中R'a,R'b,R”a和Ta如说明书中所定义, R 3,R 4表示氢或烷基,A表示式-CH(R 5)-CH(R 6) - , - CH = C(R 7) - , - C(R 7) CH(R 8) - 或-CH(R 8)-C(O) - ,其中R 5,R 6,R 7和R 8如说明书中所定义,其异构体,N-氧化物及其加成盐与药学上可接受的酸或碱 ,以及含有该药物的药物 它们可用于治疗癌症。

    Benzo[b]pyrano[3,2-h]acridin-7-one compounds

    公开(公告)号:US07056929B2

    公开(公告)日:2006-06-06

    申请号:US10627463

    申请日:2003-07-26

    IPC分类号: A61K31/44

    CPC分类号: C07D491/04

    摘要: A method for treating a living body afflicted with a cancer selected from lung and ovarian carcinoma, comprising the step of administering to the living animal body an amount of a compound selected from those of formula (I): wherein: X and Y represent group selected from hydrogen, halogen, mercapto, cyano, nitro, alkyl, trihaloalkyl, trihaloalkylcarbonylamino, —ORa, —NRaRb, —NRa—C(O)-T1, —O—C(O)-T1, —O-T2-NRaRb, —O-T2-ORa, —NRa-T2-NRaRb, —NRa-T2-ORa and —NRa-T2-CO2Ra wherein Ra, Rb, T1, T2 are as defined in the description, or X and Y together form a methylenedioxy or ethylenedioxy, R1 represents hydrogen or alkyl, R2 represents a group selected from hydrogen, —ORa, —NRaRb, —NRa—C(O)-T1, —O—C(O)-T1, —O-T2-NRaRb, —O-T2-ORa, —NRa-T2-NRaRb, —NRa-T2-ORa and —NRa-T2-CO2Ra wherein Ra, Rb, T1 and T2 are as defined hereinbefore, R3 and R4 represent hydrogen or alkyl, W represents a group of formula —CH(R5)—CH(R6)—, —CH═C(R7)—, —C(R7)═CH— or —C(O)—CH(R8)— wherein R5, R6, R7 and R8 are as defined in the description, their isomers and N-oxides, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same are useful in the treatment of cancer.